Harvard’s Dr. David Mooney to Speak on Biomaterials to Regulate Cell Trafficking

On Friday, June 12 at 2:00 p.m. Dr. David Mooney will speak on “Materials to Regulate Cell Trafficking In Vivo:  From Regeneration to Immunotherapies” in the Lipsett Amphitheater, Bldg. 10.  His talk is part of NIDCR’s seminar series “From Basic Research to Therapy—The Latest Frontier.” 

An expert in bioengineering, Dr. Mooney will discuss his work on designing versatile, active biomaterials that can program cells in vivo to survive, divide, differentiate, and migrate to specific sites in the body to heal and regenerate tissues.  Dr. Mooney’s laboratory is investigating the use of these innovative biomaterials for applications ranging from regenerative medicine to immunotherapy.  (For additional information, see Dr. Mooney’s abstract).

Dr. Mooney is the Gordon McKay Professor of Bioengineering in the School of Engineering and Applied Sciences at Harvard University.  He is also a faculty member of Harvard’s Wyss Institute for Biologically Inspired Engineering.  Dr. Mooney is a Fellow of the American Institute for Medical and Biological Engineering, an NIH MERIT awardee, and a recipient of the National Science Foundation’s CAREER award.  
If you wish to meet with Dr. Mooney during his visit to the NIH, contact Dr. Nadya Lumelsky at (301) 594-7703 or nadyal@nidcr.nih.gov.

Sign language interpretation will be provided. For more information, or for reasonable accommodation, contact Mary Daum, (301) 594-7559, and/or the Federal Relay (1-800-877-8339).

The lecture will be videocast live at http://videocast.nih.gov.

Last Reviewed on
February 2018